utilized the tissues from the glioblastoma margin to establish glioblastoma organoids (GBOs), and then cocultured the GBOs with HCMV after treatment with a 2,5-dimethylpyrrolizidine benzoic acid derivative, an EphA2 antagonist (Dong et al., 2023). This evidence concerns the gene EPHA2 and glioblastoma.